Spinal Muscular Atrophy Trial, Recruiting NCT06094205 Sponsor: Leigh R. Hochberg, MD, PhD. Condition: Spinal Muscular Atrophy
Back to Spinal Muscular Atrophy

Spinal Muscular Atrophy Trial, Recruiting

NCT06094205
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 80 years old
  • You have been diagnosed with a spinal cord injury, a brainstem stroke, muscular dystrophy, ALS (Lou Gehrig's disease), or another condition affecting movement and motor control
  • You have significant weakness or paralysis affecting both your arms and legs (either partial or complete loss of movement)
  • You live within a three-hour drive of the study location and plan to remain in the same area for at least 15 months after joining
  • There may be additional requirements not listed here (confirm with trial site)

Who may not be able to join:

  • You have a vision problem that makes it hard to look at a computer screen for extended periods of time, even when wearing glasses or contact lenses
  • You regularly take steroid medications by mouth or through an IV, or take medication that suppresses your immune system
  • You have another serious illness or condition that could make it difficult for you to take part in the study
  • There may be additional reasons that could affect eligibility not listed here (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Please note that only the trial team can confirm whether you personally qualify. This information is a simplified summary and is not medical advice.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sergey Stavisky, Ph.D., University of California, Davis

Phone: 617-724-9247

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Leigh R. Hochberg, MD, PhD.
Registry
ClinicalTrials.gov
Start date
16 October 2023
Est. completion
31 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Sensor implant duration for at least one-year without any device-related Serious Adverse Events or explant

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov